TNXP as of Nov 3 · 05:49 ET
TNXPNasdaqPharmaceutical Preparations
Tonix Pharmaceuticals Holding Corp. · Brief
Next report
6 days
Nov 9 · after closeest.Q3 FY26
Expected move
Inputs0 of 4≥ implied
- avg implied
- ±15.6%
- avg realized
- ±4.0%
Nov 12 '24—▲+3.35%—
Mar 18 '25—▼−19.78%—
May 12 '25—▲+5.16%—
Aug 11 '25—▲+32.89%—
Q3 FY25±21.1%▲+4.10%×0.19
Q1 FY26±14.0%▼−1.27%×0.09
May 11 '26±14.3%▼−5.88%×0.41
Q2 FY26±13.0%▲+4.66%×0.36
quarterimplied−35%0+35%realized×
Q2 FY26±13.0%▲+4.66%×0.36
May '26±14.3%▼−5.88%×0.41
Q1 FY26±14.0%▼−1.27%×0.09
Q3 FY25±21.1%▲+4.10%×0.19
Aug '25—▲+32.89%—
May '25—▲+5.16%—
2 older reports
Mar '25—▼−19.78%—
Nov '24—▲+3.35%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 9 report · est.Bull2 of 3
Bear2
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
TNXP report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.